22/09/2020 6:07 pm Welcome to isteroids.com - BLOG

Saturday 07, Apr 2012

  Femara- Letrozole

Posted By
Pin it Share on Tumblr

If you are looking for a potent antiestrogen that is second to none for controlling or preventing the formation of excess estrogens, Femara, also known as Liquifem and Letrozole, is the best non-steroidal aromatase inhibitor. Medically used for treating hormonally responsive breast cancer after surgery, Femara is used by sportsmen to control excess estrogen formation, just before the end or after the end of a steroid cycle involving harsh or aromatizable anabolic steroids.

Since this antiestrogen has the unique ability of minimizing the level of estrogen the human body produces, it helps sportsmen stay away from side effects of estrogens like bloating, gynecomastia, and oily skin. Femara is also useful to extend help to users when it comes to reaping and optimizing benefits of anabolic steroids during a steroid cycle besides promoting spermatogenesis in male patients suffering from non-obstructive azoospermia and treating endometriosis. If that was not all, the antiestrogen is also useful in promoting growth hormone, cortisol, SHBG, hepatic production of binding proteins, HDL, and growth and development of sexual characteristics.

The recommended dose of Letrozole for treating breast cancer patients is 2.5 mg once in a day and sportsmen often use the drug in doses of 0.25-1.0 mg per day, with or without meals. Letrozole abuse may lead to side effects including loss of appetite, headache, stomach pain, cough, hot flushes, night sweats, vomiting, and breast pain.

Letrozole use is extremely helpful in reaping benefits of “good” estrogens like healthy immune function, healthy cholesterol levels, joint health, cognitive function, and muscle growth while “bad” estrogens are eliminated by Femara to help users stay away from estrogen side effects (excess estrogen side effects) like oily skin, acne, and gynecomastia.

Monday 23, Aug 2010

  Airway constriction in asthmatic women patients reduces with estrogen

Posted By
Pin it Share on Tumblr

Airway constriction in asthmatic women patients reduces with estrogenAccording to new bench research from the Mayo Clinic, female sex hormones could work with beta-agonists in minimizing airway constriction.

Lead student researcher, Elizabeth A. Townsend, of the Mayo Clinic Department of Physiology and Biomedical Engineering, said that it will be of interest to ascertain whether sex steroids such as estrogen and progesterone play a role in modulation of airway tone.

The findings are being presented at the ATS 2010 International Conference in New Orleans.